US 11891431
Removal of serine proteases by treatment with finely divided silicon dioxide
granted A61KA61K35/16A61K38/1709
Quick answer
US patent 11891431 (Removal of serine proteases by treatment with finely divided silicon dioxide) held by Takeda Pharm Limited ceutical Company Limited expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharm Limited ceutical Company Limited
- Grant date
- Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K35/16, A61K38/1709, A61K39/39525, A61K47/183